As of 4:01pm ET
| -0.0059 / -1.49%|
The 5 analysts offering 12-month price forecasts for Mast Therapeutics Inc have a median target of 2.50, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +541.03% increase from the last price of 0.39.
The current consensus among 5 polled investment analysts is to Buy stock in Mast Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.